Revium Rx.
RVRC· OTC
RVRCRevium Rx.
Filed May 14, 2026 · 10-Q · 44 days after period end · 0001213900-26-056600
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$725.00K | -$634.00K |
| EPS Diluted | $0.01 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end
Revium Rx. · CIK 1839140 · Engraved from SEC EDGAR
